drugset / Trial / NCT00807937
Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7325 | Small molecule | 5 mg | Oral |
| Subject | AZD7325 | Small molecule | 15 mg | Oral |
| Comparator | Lorazepam | Small molecule | 2 mg | Oral |